Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:01 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2113–2136 of 6,310 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Metabolism and Nutrition Disorders Clear all

Conditions: Weight Loss, Obesity, Childhood, Obesity
Interventions: Lomaira 8Mg Tablet; Drug
Lead sponsor: Loma Linda University; Other
Eligibility: 12 Months to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Loma Linda, California

Conditions: Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions: exercise; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Metabolism and Nutrition Disorder, Overweight or Obesity
Interventions: Semaglutide, Placebo (semaglutide); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 1,961 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 39
States / cities: Anniston, Alabama • Anaheim, California • Lomita, California + 32 more

Conditions: Insulin Resistance, Polycystic Ovary Syndrome, Hyperinsulinism, Obesity, Metabolic Syndrome
Interventions: Not listed
Lead sponsor: Ali Chappell; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Vitamin D Deficiency
Interventions: 1,000 IU vitamin D2, placebo capsule, mushrooms, UVB-treated mushrooms, 400 IU vitamin D2, UVB-treated mushrooms, 1,000 IU vitamin D2; Dietary Supplement · Other
Lead sponsor: USDA, Western Human Nutrition Research Center; Federal
Eligibility: 20 Years to 59 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Davis, California

Conditions: Eating Disorders, Obesity
Interventions: Body Project; Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: Female only
Enrollment: 432 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 7
States / cities: Eugene, Oregon • Philadelphia, Pennsylvania • Austin, Texas + 1 more

Conditions: Chronic Heart Failure, Chronic Obstructive Pulmonary Disorder
Interventions: BOOST High Protein; Dietary Supplement
Lead sponsor: Texas A&M University; Other
Eligibility: 20 Years and older
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Metabolically Healthy Obesity
Interventions: Inulin Supplementation, Maltodextrin (Placebo), High-fat meal; Dietary Supplement · Other
Lead sponsor: Ball State University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Muncie, Indiana

Conditions: Hematopoietic Stem Cell Transplantation, Delirium, Thiamine Deficiency
Interventions: Thiamine, Normal saline; Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Overweight, Obesity
Interventions: Semaglutide, Placebo (semaglutide), Liraglutide, Placebo (liraglutide); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 338 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 19
States / cities: Birmingham, Alabama • Fullerton, California • Huntington Beach, California + 15 more

Conditions: Non-Alcoholic Fatty Liver Disease, Obesity
Interventions: Alternate day fasting, Exercise; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Gestational Diabetes, Obesity, Pregnancy, High Risk
Interventions: Blueberry + soluble fiber; Dietary Supplement
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 19 Years to 40 Years · Female only
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Insulin Resistance, Hyperinsulinemia, Obesity
Interventions: Diazoxide, 3 mg/kg per dose; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity
Interventions: Exercise; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 40 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Cardiovascular Disease
Interventions: Rimonabant, Placebo (for Rimonabant); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 55 Years and older
Enrollment: 18,695 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Metabolic Syndrome, Insulin Sensitivity, Cardiovascular Diseases
Interventions: Phosphorus-supplemented study diet, Control Diet; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 45 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Overweight and Obesity
Interventions: Home weight loss program; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Obesity
Interventions: Healthy Weight; Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: 17 Years to 19 Years · Female only
Enrollment: 405 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Cardiovascular Diseases, Metabolic Syndrome, Obesity, Prediabetes, Mental Health Disorders, Endocrine Dysfunction, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease (CKD)
Interventions: Blood Work; Other
Lead sponsor: Clindove Research LLC; Other
Eligibility: 18 Years and older
Enrollment: 7,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Asthma, Obesity
Interventions: Beclomethasone dipropionate HFA, Tiotropium bromide, Salmeterol xinafoate; Drug
Lead sponsor: National Jewish Health; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 10
States / cities: San Diego, California • San Francisco, California • Denver, Colorado + 7 more

Conditions: Environmental Exposures, Child Development, Lead and Injury Reduction
Interventions: Lead Hazard Control Intervention, Injury Hazard Control Intervention; Procedure
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 468 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2018
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Cardiovascular Risk Factor, Circadian Dysregulation, Obesity
Interventions: Positron Emission Tomography (PET) scanning of cardiac function at 3 time points across the 24 hour circadian cycle; Combination Product
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 25 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Obesity, Food Cravings, Weight Loss
Interventions: Test two food cravings strategies during dietary weight loss, Dietary weight loss program +Food cravings strategies; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Obesity, Hypercholesterolemia, Hyperglycemia, Hypertriglyceridemia
Interventions: Mediterranean Lemonade, Green Tea, Flavored Water; Other
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 64 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Tucson, Arizona

Search by objective public record fields.

Treating Toddler Obesity by Treating the Parent/Caregiver Obesity With Weight Loss Medications

Exercise Dose and Nonalcoholic Fatty Liver Disease

STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Effect of Consumption of Post-harvest UV-B Treated Mushrooms on Vitamin D Status of Healthy Adults

Eating Disorders Prevention: An Effectiveness Trial for At-Risk College Students

Nutritional and Functional Changes in Heart Failure and COPD

Gut, Immune, and Vascular Health in Metabolically Healthy Obesity

High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation

Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity

Alternate Day Fasting, Exercise, and NAFLD

Healthy Diet for Healthy Moms and Babies

Diazoxide Suppression Test P&F Study

Effect of Exercise on Metabolic Health

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

Effect of Phosphorus Additives on the Metabolome in Healthy Adults

Pilot Study of the HWL Program

Targeted Obesity Prevention Program for Adolescent Females

Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications

HOME Study (Health Outcomes and Measures of the Environment Study)

Body Weight, Sleep, and Heart Health

Food Cravings Strategies During Dietary Weight Loss

Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults